5-HT1A and 5-HT2A receptors minimally contribute to clozapine-induced acetylcholine release in rat medial prefrontal cortex

Brain Research

Volumn 939, Issue 1-2, 2002, Pages 34-42

  Ichikawa, Junji ^a,b   Dai, Jin ^a   Meltzer, Herbert Y ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Psychiatric Hospital at Vanderbilt   (United States)

Author keywords

5 HT1A receptor; 5 HT2A receptor; Acetycholine release; Clozapine; Haloperidol; Medial prefrontal cortex

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; 4 IODO 2,5 DIMETHOXYAMPHETAMINE; ACETYLCHOLINE; ALPHA (2,3 DIMETHOXYPHENYL) 1 [2 (4 FLUOROPHENYL)ETHYL] 4 PIPERIDINEMETHANOL; CLOZAPINE; HALOPERIDOL; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; SEROTONIN 1 AGONIST; SEROTONIN 1A ANTAGONIST; SEROTONIN 1A RECEPTOR; SEROTONIN 2A AGONIST; SEROTONIN 2A ANTAGONIST; SEROTONIN 2A RECEPTOR; SEROTONIN 2C AGONIST;

ACETYLCHOLINE RELEASE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DRUG EFFECT; DRUG INHIBITION; MALE; NONHUMAN; NUCLEUS ACCUMBENS; PREFRONTAL CORTEX; PRIORITY JOURNAL; RAT;

8-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN; ACETYLCHOLINE; ANIMALS; CLOZAPINE; CORPUS STRIATUM; DOPAMINE ANTAGONISTS; FLUOROBENZENES; HALOPERIDOL; INDOPHENOL; MALE; MICRODIALYSIS; NUCLEUS ACCUMBENS; PIPERAZINES; PIPERIDINES; PREFRONTAL CORTEX; PYRIDINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, SEROTONIN, 5-HT2A; RECEPTORS, SEROTONIN; RECEPTORS, SEROTONIN, 5-HT1; SEROTONIN AGONISTS; SEROTONIN ANTAGONISTS; TIME FACTORS;

EID: 0037036059     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(02)02544-1     Document Type: Article

References (74)

1. 1 receptors regulate striatal acetylcholine release in vivo
2. 2 receptors: An autoradiographic analysis in rat brain
3. 1C receptors in rat brain
4. 1A receptor agonist properties of the antipsychotic, nemonapride: Comparison with bromerguride and clozapine
5. A review of central 5-HT receptors and their function
6. Modulation of cortical in vivo acetylcholine release by the basal nuclear complex: Role of the pontomesencephalic tegmental area
7. Antagonism by antimuscarinic and neuroleptic compounds at the five cloned human muscarinic cholinergic receptors expressed in Chinese hamster ovary cells
8. 2 receptor antagonist, potentiates haloperidol (HAL)-induced dopamine (DA) release in the medial prefrontal cortex (mPFC) and nucleus accumbens (NAC)
9. 2C receptor antagonist
10. Potential role of muscarinic receptors in schizophrenia
11. 1-adrenergic receptors in vitro
12. 1B receptors
13. 1A-mediated facilitation of in vivo acetylcholine release in rat frontal cortex
14. 1-receptor stimulation in shell and core of nucleus accumbens
15. 2A receptor-mediated behaviour in mice during the day but not at night
16. Dopaminergic regulation of cortical acetylcholine release: Effects of dopamine receptor agonists
17. 2 dopamine receptor subtypes
18. 3 receptors and GABAergic neuron: Inhibiting acetylcholine release in rat entorhinal cortex slices
19. 7 receptors in the suprachiasmatic nucleus
20. Central cholinergic systems and cognition
21. Pharmacological characterization of serotonin receptor subtypes modulating primary afferent input to deep dorsal horn neurons in the neonatal rat
22. Acetylcholine release from the frontal cortex during exploratory activity
23. 2A receptor activation enhances dialysis levels of dopamine and noradrenaline, but not 5-HT, in the frontal cortex of freely moving rats
24. 2-adrenoceptor antagonism
25. Serotonergic regulation of acetylcholine release in rat frontal cortex
26. 1A receptors
27. International union of pharmacology classification of receptors for 5-hydroxytryptamine (serotonin)
28. Effect of antipsychotic drugs on extracellular serotonin levels in rat medial prefrontal cortex and nucleus accumbens
29. Acetylcholinesterase inhibitors are neither necessary nor desirable for microdialysis studies of brain acetylcholine
30. 1A receptor activation: A possible mechanism of atypical antipsychotic-induced cortical dopamine release
31. 2A/2C receptor agonist, attenuates clozapine-induced cortical dopamine release
32. Cholinergic modulation of basal and amphetamine (AMP)-induced dopamine (DA) release in rat medial prefrontal cortex (mPFC) and nucleus accumbens (NAC)
33. Atypical, but not typical, antipsychotic drugs increase cortical acetylcholine release without an effect in the nucleus accumbens or striatum
34. 1 receptors
35. 1A receptor agonist, 8-OH-DPAT, locally administered into the dorsal raphe nucleus increased extracellular acetylcholine concentrations in the medial prefrontal cortex of conscious rats
36. Striatal interneurones: Chemical, physiological and morphological characterization
37. 1A receptor-mediated pathways by BAYx3702 in freely moving rats
38. Effect of antipsychotic drugs on extracellular dopamine levels in rat medial prefrontal cortex and nucleus accumbens
39. Efficacy and extrapyramidal side effects of the new antipsychotics olanzapine, quetiapine, risperidone, and sertindole compared to conventional antipsychotics and placebo. A meta-analysis of randomized controlled trials
40. Olanzapine increases in vivo dopamine and norepinephrine release in rat prefrontal cortex, nucleus accumbens and striatum
41. 2A receptor antagonist, potentiates haloperidol-induced dopamine (DA) release in the medial prefrontal cortex (mPFC), but inhibits that in the nucleus accumbens (NAC)
42. 4 receptors in cholinergic function associated with cognitive processes: Behavioral, electrophysiological, and neurochemical studies
43. i values
44. The effects of clozapine, risperidone, and olanzapine on cognitive function in schizophrenia
45. The role of serotonin in antipsychotic drug action
46. Acute effects of typical and atypical antipsychotic drugs on the release of dopamine from prefrontal cortex, nucleus accumbens, and striatum of the rat: An in vivo microdialysis study
47. 2 receptors in the rat brain
48. 1A receptor agonist, in normal and p-chlorophenylalanine-treated rats as measured by in vivo microdialysis
49. 35S]GTPgS
50. Selective action of acute systemic clozapine on acetylcholine release in the rat prefrontal cortex by reference to the nucleus accumbens and striatum
51. 2A antagonist, attenuates dopamine release in the rat medial prefrontal cortex
52. In vivo modulation of acetylcholine in the nucleus accumbens of freely moving rats: I. Inhibition by serotonin
53. 1A receptor activation
54. 1C receptors
55. 7 receptors
56. 7) activating cAMP formation
57. Cognitive functions of cortical acetylcholine: Toward a unifying hypothesis
58. Risperidone compared with new and reference antipsychotic drugs: In vitro and in vivo receptor binding
59. Ziprasidone (CP-88,059): A new antipsychotic with combined dopamine and serotonin receptor antagonist activity
60. Dopamine receptor pharmacology
61. 1A receptor agonist, facilitates cortical acetylcholine release by a mechanism different from that of 8-OH-DPAT in awake rats
62. 1 agonist dihydrexidine releases acetylcholine and improves cognitive performance in rats
63. Cholinergic hyperactivity and negative schizophrenic symptoms, a model of cholinergic/dopaminergic interactions in schizophrenia
64. Cholinergic aspects of schizophrenia
65. 7 receptors: Current knowledge and future prospects
66. BIMG 80, a novel potential antipsychotic drug: Evidence for multireceptor actions and preferential release of dopamine in prefrontal cortex
67. 2A receptor agonists into the medial prefrontal cortex produces a head-twitch response in rats
68. 4 receptor involvement in the enhancement of acetylcholine release by p-chloroamphetamine in rat frontal cortex
69. 4 receptors
70. 2A/2C receptors within the nucleus accumbens increases local dopaminergic transmission
71. 2A receptor stimulation in rats pretreated with intermittent cocaine
72. Increase of cortical acetylcholine release after systemic administration of chlorophenylpiperazine in the rat: An in vivo microdialysis study
73. 2C receptors